These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27552516)

  • 41. Adherence with topical glaucoma medication monitored electronically the Travatan Dosing Aid study.
    Okeke CO; Quigley HA; Jampel HD; Ying GS; Plyler RJ; Jiang Y; Friedman DS
    Ophthalmology; 2009 Feb; 116(2):191-9. PubMed ID: 19084273
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Automated telecommunication-based reminders and adherence with once-daily glaucoma medication dosing: the automated dosing reminder study.
    Boland MV; Chang DS; Frazier T; Plyler R; Jefferys JL; Friedman DS
    JAMA Ophthalmol; 2014 Jul; 132(7):845-50. PubMed ID: 24831037
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of the Xal-Ease latanoprost delivery system.
    Semes L; Shaikh AS
    Optometry; 2007 Jan; 78(1):30-3. PubMed ID: 17208672
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence and determinants of non-adherence to topical hypotensive treatment in Dutch glaucoma patients.
    Olthoff CM; Hoevenaars JG; van den Borne BW; Webers CA; Schouten JS
    Graefes Arch Clin Exp Ophthalmol; 2009 Feb; 247(2):235-43. PubMed ID: 18802720
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Alterations of intraocular pressure in comparison of self- and external-administered topical antiglaucomatosa during diurnal intraocular pressure measurements].
    Böhm MR; Lill TM; Eter N; Prokosch-Willing V
    Klin Monbl Augenheilkd; 2014 Aug; 231(8):810-7. PubMed ID: 25133559
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Exploring the frequency and location of prescribing errors in the use of topical glaucoma medications.
    Lakhani BK; King AJ
    Clin Exp Ophthalmol; 2018 Aug; 46(6):616-623. PubMed ID: 29360241
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Validation of a short version of the glaucoma medication self-efficacy questionnaire.
    Sleath B; Blalock SJ; Stone JL; Skinner AC; Covert D; Muir K; Robin AL
    Br J Ophthalmol; 2012 Feb; 96(2):258-62. PubMed ID: 21610264
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparing the effectiveness of selective laser trabeculoplasty with topical medication as initial treatment (the Glaucoma Initial Treatment Study): study protocol for a randomised controlled trial.
    Lamoureux EL; Mcintosh R; Constantinou M; Fenwick EK; Xie J; Casson R; Finkelstein E; Goldberg I; Healey P; Thomas R; Ang GS; Pesudovs K; Crowston J
    Trials; 2015 Sep; 16():406. PubMed ID: 26362541
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Introduction: new insights on enhancing adherence to topical glaucoma medications.
    Friedman DS
    Ophthalmology; 2009 Nov; 116(11 Suppl):S29. PubMed ID: 19837257
    [No Abstract]   [Full Text] [Related]  

  • 50. Measurement of adherence to brimonidine therapy for glaucoma using electronic monitoring.
    Hermann MM; Bron AM; Creuzot-Garcher CP; Diestelhorst M
    J Glaucoma; 2011 Oct; 20(8):502-8. PubMed ID: 20852438
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Persistency with glaucoma medication.
    Fiscella RG
    Am J Ophthalmol; 2004 Dec; 138(6):1093-4; author reply 1094. PubMed ID: 15629333
    [No Abstract]   [Full Text] [Related]  

  • 52. Squeezability of eye drop containers used in dry eye disease management.
    Bitton E; Bouskila J
    Clin Exp Optom; 2024 Jun; ():1-6. PubMed ID: 38858843
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Barriers to glaucoma drug delivery.
    Ghate D; Edelhauser HF
    J Glaucoma; 2008 Mar; 17(2):147-56. PubMed ID: 18344762
    [TBL] [Abstract][Full Text] [Related]  

  • 54. iStent as a Solo Procedure for Glaucoma Patients: A Systematic Review and Meta-Analysis.
    Malvankar-Mehta MS; Chen YN; Iordanous Y; Wang WW; Costella J; Hutnik CM
    PLoS One; 2015; 10(5):e0128146. PubMed ID: 26018579
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reduction of Eyedrop Volume for Topical Ophthalmic Medications with the Nanodropper Bottle Adaptor.
    St Peter DM; Steger JS; Patnaik JL; Davis N; Kahook MY; Seibold LK
    Med Devices (Auckl); 2023; 16():71-79. PubMed ID: 37056302
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of eye drop administration technique in patients with glaucoma or ocular hypertension.
    Schwartz GF; Hollander DA; Williams JM
    Curr Med Res Opin; 2013 Nov; 29(11):1515-22. PubMed ID: 24006861
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preferences for eye drop characteristics among glaucoma specialists: a willingness-to-pay analysis.
    Jampel HD; Parekh P; Johnson E; Robin AL; Miller RB
    J Glaucoma; 2005 Apr; 14(2):151-6. PubMed ID: 15741818
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medications.
    Fechtner RD; Godfrey DG; Budenz D; Stewart JA; Stewart WC; Jasek MC
    Cornea; 2010 Jun; 29(6):618-21. PubMed ID: 20386433
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A study of the causes of non-compliance by patients prescribed eyedrops.
    Winfield AJ; Jessiman D; Williams A; Esakowitz L
    Br J Ophthalmol; 1990 Aug; 74(8):477-80. PubMed ID: 2390523
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Innovative bulls eye drop applicator for self-instillation of eye drops.
    Taneja M; Chappidi K; Harsha Ch SNS; Richhariya A; Mohamed A; Rathi VM
    Cont Lens Anterior Eye; 2020 Jun; 43(3):256-260. PubMed ID: 31813766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.